Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slipped 1.26% to $72.34 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.31% to 33,733.96 and the S&P 500 Index falling 0.07% to 4,016.95. This was the stock's second consecutive day of losses. Bristol Myers Squibb Co. closed $9.10 short of its 52-week high ($81.44), which the company reached on December 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) remained unchanged, Pfizer Inc. (PFE) fell 0.60% to $44.71, and Abbott Laboratories (ABT) fell 1.30% to $112.53. Trading volume (7.3 M) remained 1.8 million below its 50-day average volume of 9.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 24, 2023.
(END) Dow Jones Newswires
January 24, 2023 16:42 ET (21:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.